← All Advisories
Reported from OT-Advisories.com as of

CVE-2025-61624: Fortinet Multiple Products

Last refreshed2026-10-18

Status: KEV  |  Advisory ID: CVE-2025-61624

Key Details

CVECVE-2025-61624
Vulnerability NameFortinet Multiple Products Path Traversal Vulnerability
Affected products
Fortinet Multiple Products
Exploitation status
Listed in CISA's Known Exploited Vulnerabilities (KEV) catalog, indicating confirmed active exploitation.
Classified as
CWE-22 (Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'))
KEV listing
Added to CISA's Known Exploited Vulnerabilities (KEV) catalog on 2026-10-16.
Federal remediation deadline
2026-10-19 (CISA KEV, Binding Operational Directive).

Affected Products, Subsystems & Sectors

VendorProductAffected VersionsPatch Status
FortinetMultiple Products
SubsystemsIndustrial Networking & Connectivity
SectorsMulti-sector

What to Know

FortiOS, FortiPAM, FortiProxy, and FortiSwitchManager contain a path traversal vulnerability that may allow an authenticated attacker with admin profile and at least read-write permissions to write or delete arbitrary files via specific CLI commands.

What to Do

Monitor Fortinet's web page for any future patch releases.

References

SourceReference
NVDhttps://nvd.nist.gov/vuln/detail/CVE-2025-61624
CVEhttps://www.cve.org/CVERecord?id=CVE-2025-61624

KEV Required Action

FieldValue
KEV Linkhttps://www.cisa.gov/known-exploited-vulnerabilities-catalog
Date Added to KEV2026-10-16
Required Action Due Date2026-10-19
Required ActionApply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.
Report compilation © 2026 OT-Advisories.com  ·  CC BY 4.0  ·  Source materials remain the property of their respective publishers as cited.